Proceeds to Enable Commercialization and Scale-Up of Unique RNA Sequencing Technology. Lausanne, Switzerland – Alithea Genomics, a fast-growing, emerging leader in the field of RNA sequencing and transcriptomics analysis, announced today the closing of a CHF 1 million seed financing round led by the Novalis Biotech Acceleration fund, with participation of Swiss-based private investors. Alithea has developed […]
GeoMx NextSeq workflow creates a streamlined end-to-end solution for spatial multiomic analysis, reducing user touchpoints, and the need for on-site informatics infrastructure SEATTLE — NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a seamless, cloud-based workflow that improves the spatial data analysis experience of […]
– Cooperates with scientists from Lund University to develop improved bladder cancer diagnostics Qlucore – listed on Nasdaq First North – is delighted to announce a new collaboration in the field of precision diagnostics to develop solutions for improved clinical diagnostics of bladder cancer. Bladder cancer is the third classifier model co-operation launched by Qlucore in […]
The collaboration includes custom genotyping arrays designed to accelerate genomic research and clinical applications of predictive genomics across Arab populations WALTHAM, Mass. – Thermo Fisher Scientific, the world leader in serving science, and Qatar Genome Program (QGP), a member of Qatar Foundation (QF), have partnered with the goal of accelerating genomic research and clinical applications of […]
QIAwave products showed 35% lower environmental impact First in industry to receive ACT label for sample preparation kits QIAGEN and My Green Lab to collaborate on laboratory sustainability efforts HILDEN, Germany & GERMANTOWN, Md. — QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its recently launched, environmentally friendlier QIAwave nucleic-acid extraction kits […]
Instand-NGS4P is a H2020 funded project for improving cancer patients’ benefit from Next Generation Sequencing (NGS) by developing an integrated and standardized NGS workflow and integrating information from cancer gene testing, pharmacogenetics testing and e-medication in proper presentation to medical doctors to support therapy decision at bedside. The project started in January 2020 and has […]
HELSINKI, Finland. Euformatics, BC Platforms and Oncompass Medicine formed a partnership to bid for the development of standardized oncology workflows for a buyer consortium of seven leading hospitals* based in Central Europe and co-funded by the European Union Grant Agreement n° 874719. The buyer consortium, represented by the Medical University Graz, evaluated all proposals and awarded […]
Study will evaluate whether blood-based testing can inform oncology providers about genetic variations within a patient’s cancer, which may influence choice of treatment based on cancer stage and type SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) a global leader in DNA sequencing and array-based technologies, and Allegheny Health Network (AHN), an integrated health system serving the Western Pennsylvania […]
Alliance Pharma, a US-based Bioanalytical CRO and an Ampersand portfolio company, has agreed to acquire DDS, a UK-based Bioanalytical Business Unit of LGC. KKR will become an equal shareholder in the combined business alongside Ampersand Capital Partners. Backed by Ampersand and KKR, Alliance and DDS plan to expand the company’s geographic reach, broaden its laboratory […]
LONGMONT, Colo. — KromaTiD a single-cell analysis company focused on the research, development, and commercialization of technology solutions for the cell and gene therapy market, announces the launch of KromaTiD Pinpoint FISH™ Probes. This product offering expands on our 10 years of service providing high-resolution assays with superior detection, and robust data, for our client’s large […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
